Report for: HMG CoA reductase inhibitors (statins) for dialysis patients

Title	HMG CoA reductase inhibitors (statins) for dialysis patients
Published in	Cochrane database of systematic reviews, September 2013
DOI	10.1002/14651858.cd004289.pub5
Pubmed ID	24022428
Authors	Suetonia C Palmer, Sankar D Navaneethan, Jonathan C Craig, David W Johnson, Vlado Perkovic, Sagar U Nigwekar, Jorgen Hegbrant, Giovanni FM Strippoli
Abstract	People with advanced kidney disease treated with dialysis experience mortality rates from cardiovascular disease that are substantially higher than for the general population. Studies that have assessed the benefits of statins (HMG CoA reductase inhibitors) report conflicting conclusions for people on dialysis and existing meta-analyses have not had sufficient power to determine whether the effects of statins vary with severity of kidney disease. Recently, additional data for the effects of statins in dialysis patients have become available. This is an update of a review first published in 2004 and last updated in 2009.

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 24 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
Australia	4	17%
Spain	3	13%
Canada	2	8%
Nigeria	1	4%
Saudi Arabia	1	4%
United Kingdom	1	4%
Colombia	1	4%
Netherlands	1	4%
Unknown	10	42%

Demographic breakdown

Type	Count	As %
Members of the public	17	71%
Scientists	4	17%
Practitioners (doctors, other healthcare professionals)	2	8%
Science communicators (journalists, bloggers, editors)	1	4%

Mendeley readers

The data shown below were compiled from readership statistics for 210 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
United States	1	<1%
India	1	<1%
Australia	1	<1%
Unknown	207	99%

Demographic breakdown

Readers by professional status	Count	As %
Student > Master	36	17%
Student > Bachelor	28	13%
Researcher	17	8%
Student > Postgraduate	17	8%
Other	15	7%
Other	44	21%
Unknown	53	25%

Readers by discipline	Count	As %
Medicine and Dentistry	94	45%
Nursing and Health Professions	18	9%
Pharmacology, Toxicology and Pharmaceutical Science	8	4%
Agricultural and Biological Sciences	6	3%
Psychology	6	3%
Other	16	8%
Unknown	62	30%

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2022.

All research outputs

#1,566,761

of 23,905,714 outputs

Outputs from Cochrane database of systematic reviews

#3,568

of 12,768 outputs

Outputs of similar age

#14,201

of 201,833 outputs

Outputs of similar age from Cochrane database of systematic reviews

#81

of 238 outputs

Altmetric has tracked 23,905,714 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 12,768 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.7. This one has gotten more attention than average, scoring higher than 72% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 201,833 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.

We're also able to compare this research output to 238 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.

Cochrane Database of Systematic Reviews

HMG CoA reductase inhibitors (statins) for dialysis patients

About this Attention Score

Mentioned by

Citations

Readers on

Twitter Demographics

Geographical breakdown

Demographic breakdown

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context